Human ovarian cancers specifically bind daunorubicin-OC-125 conjugate: an immunofluorescence study.
Dezsö B, Török I, Rosik LO, Sweet F.
Dezsö B, et al. Among authors: sweet f.
Gynecol Oncol. 1990 Oct;39(1):60-4. doi: 10.1016/0090-8258(90)90399-6.
Gynecol Oncol. 1990.
PMID: 2227573
We recently reported that the DNR-OC-125 conjugate is selectively toxic in vitro to dividing cell populations of the human ovarian cancer cell lines SK-OV-3 and OVCAR-3 that express the CA-125 antigen [F. Sweet, L. O. Rosik, G. M. Sommers, and J. L. Collins, Gynecol …
We recently reported that the DNR-OC-125 conjugate is selectively toxic in vitro to dividing cell populations of the human ovarian cancer ce …